Faron Pharmaceuticals Oy (4FR) Financial Statements
Faron Pharmaceuticals Oy Financial Overview
Faron Pharmaceuticals Oy's market cap is currently $75.07M. The company's EPS TTM is ―; its P/E ratio is -2.99; Faron Pharmaceuticals Oy is estimated to report earnings on March 19, 2027, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ― | ― | ― | ― | ― |
| Gross Profit | $ 803.00K | ― | ― | ― | ― |
| Operating Income | $ -27.43M | $ -21.11M | $ -16.65M | $ -13.10M | $ -19.65M |
| EBITDA | $ -27.05M | $ -20.96M | $ -16.79M | $ -13.10M | $ -19.86M |
| Net Income | $ -28.73M | $ -21.19M | $ -16.94M | $ -13.26M | $ -20.09M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ― | ― | ― | ― | ― |
| Total Assets | $ 11.27M | $ 13.18M | $ 8.37M | $ 10.21M | $ 8.00M |
| Total Debt | $ 13.27M | $ 3.55M | $ 3.23M | $ 2.82M | $ 2.13M |
| Net Debt | $ 6.28M | $ -3.31M | $ -883.00K | $ -4.24M | $ -1.94M |
| Total Liabilities | $ 22.75M | $ 10.26M | $ 10.22M | $ 8.60M | $ 7.63M |
| Stockholders' Equity | ― | ― | ― | ― | ― |
| Cash Flow | |||||
| Free Cash Flow | $ -23.38M | $ -22.22M | ― | ― | $ -20.82M |
| Operating Cash Flow | ― | ― | ― | ― | ― |
| Investing Cash Flow | ― | ― | ― | ― | ― |
| Financing Cash Flow | ― | ― | ― | ― | ― |
Currency in USD
